141 related articles for article (PubMed ID: 24219291)
21. Collagenolytic matrix metalloproteinases antagonize proteinase-activated receptor-2 activation, providing insights into extracellular matrix turnover.
Falconer AMD; Chan CM; Gray J; Nagashima I; Holland RA; Shimizu H; Pickford AR; Rowan AD; Wilkinson DJ
J Biol Chem; 2019 Jun; 294(26):10266-10277. PubMed ID: 31110047
[TBL] [Abstract][Full Text] [Related]
22. Effects of trypsin, thrombin and proteinase-activated receptors on guinea pig common bile duct motility.
Huang SC
Regul Pept; 2012 Nov; 179(1-3):1-5. PubMed ID: 22960409
[TBL] [Abstract][Full Text] [Related]
23. Differential effects of serine proteases on the migration of normal and tumor cells: implications for tumor microenvironment.
Elzer KL; Heitzman DA; Chernin MI; Novak JF
Integr Cancer Ther; 2008 Dec; 7(4):282-94. PubMed ID: 19116224
[TBL] [Abstract][Full Text] [Related]
24. Activity of recombinant trypsin isoforms on human proteinase-activated receptors (PAR): mesotrypsin cannot activate epithelial PAR-1, -2, but weakly activates brain PAR-1.
Grishina Z; Ostrowska E; Halangk W; Sahin-Tóth M; Reiser G
Br J Pharmacol; 2005 Dec; 146(7):990-9. PubMed ID: 16231009
[TBL] [Abstract][Full Text] [Related]
25. Protease-activated receptor isoform expression in pregnant and nonpregnant rat myometrial tissue.
Chien EK; Sweet L; Phillippe M; Marietti S; Kim TT; Wolff DA; Thomas L; Bieber E
J Soc Gynecol Investig; 2003 Dec; 10(8):460-8. PubMed ID: 14662158
[TBL] [Abstract][Full Text] [Related]
26. The ecotin-like peptidase inhibitor of Trypanosoma cruzi prevents TMPRSS2-PAR2-TLR4 crosstalk downmodulating infection and inflammation.
Costa TFR; Catta-Preta CMC; Goundry A; Carvalho DB; Rodrigues NS; Vivarini AC; de Abreu MF; Reis FCG; Lima APCA
FASEB J; 2024 Mar; 38(6):e23566. PubMed ID: 38526868
[TBL] [Abstract][Full Text] [Related]
27. Modulation of expression of innate immunity markers CXCL5/ENA-78 and CCL20/MIP3alpha by protease-activated receptors (PARs) in human gingival epithelial cells.
Rohani MG; Beyer RP; Hacker BM; Dommisch H; Dale BA; Chung WO
Innate Immun; 2010 Apr; 16(2):104-14. PubMed ID: 19567485
[TBL] [Abstract][Full Text] [Related]
28. Modulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110).
Suen JY; Barry GD; Lohman RJ; Halili MA; Cotterell AJ; Le GT; Fairlie DP
Br J Pharmacol; 2012 Mar; 165(5):1413-23. PubMed ID: 21806599
[TBL] [Abstract][Full Text] [Related]
29. Proteinase-activated receptor 2-mediated potentiation of transient receptor potential vanilloid subfamily 1 activity reveals a mechanism for proteinase-induced inflammatory pain.
Dai Y; Moriyama T; Higashi T; Togashi K; Kobayashi K; Yamanaka H; Tominaga M; Noguchi K
J Neurosci; 2004 May; 24(18):4293-9. PubMed ID: 15128843
[TBL] [Abstract][Full Text] [Related]
30. The PAR2 signal peptide prevents premature receptor cleavage and activation.
Liu B; Lee G; Wu J; Deming J; Kuei C; Harrington A; Wang L; Towne J; Lovenberg T; Liu C; Sun S
PLoS One; 2020; 15(2):e0222685. PubMed ID: 32078628
[TBL] [Abstract][Full Text] [Related]
31. Molecular mechanisms regulating Proteinase-Activated Receptors (PARs).
Chandrabalan A; Ramachandran R
FEBS J; 2021 Apr; 288(8):2697-2726. PubMed ID: 33742547
[TBL] [Abstract][Full Text] [Related]
32. Thrombin cleaves and activates the protease-activated receptor 2 dependent on thrombomodulin co-receptor availability.
Heuberger DM; Franchini AG; Madon J; Schuepbach RA
Thromb Res; 2019 May; 177():91-101. PubMed ID: 30861432
[TBL] [Abstract][Full Text] [Related]
33. Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory disease.
Hollenberg MD; Mihara K; Polley D; Suen JY; Han A; Fairlie DP; Ramachandran R
Br J Pharmacol; 2014 Mar; 171(5):1180-94. PubMed ID: 24354792
[TBL] [Abstract][Full Text] [Related]
34. Substrate specificity determination of mouse implantation serine proteinase and human kallikrein-related peptidase 6 by phage display.
Sharma N; Oikonomopoulou K; Ito K; Renaux B; Diamandis EP; Hollenberg MD; Rancourt DE
Biol Chem; 2008 Aug; 389(8):1097-105. PubMed ID: 18979633
[TBL] [Abstract][Full Text] [Related]
35. Autocrine proteinase-activated receptor signaling in PC3 prostate cancer cells.
Chandrabalan A; Ramachandran R
Am J Physiol Cell Physiol; 2023 Jul; 325(1):C272-C285. PubMed ID: 37273236
[TBL] [Abstract][Full Text] [Related]
36. Modified proteinase-activated receptor-1 and -2 derived peptides inhibit proteinase-activated receptor-2 activation by trypsin.
Al-Ani B; Saifeddine M; Wijesuriya SJ; Hollenberg MD
J Pharmacol Exp Ther; 2002 Feb; 300(2):702-8. PubMed ID: 11805236
[TBL] [Abstract][Full Text] [Related]
37. Enzyme specificity and effects of gyroxin, a serine protease from the venom of the South American rattlesnake Crotalus durissus terrificus, on protease-activated receptors.
Yonamine CM; Kondo MY; Nering MB; Gouvêa IE; Okamoto D; Andrade D; da Silva JA; Prieto da Silva AR; Yamane T; Juliano MA; Juliano L; Lapa AJ; Hayashi MA; Lima-Landman MT
Toxicon; 2014 Mar; 79():64-71. PubMed ID: 24412460
[TBL] [Abstract][Full Text] [Related]
38. Determinants of the specificity of protease-activated receptors 1 and 2 signaling by factor Xa and thrombin.
Rana S; Yang L; Hassanian SM; Rezaie AR
J Cell Biochem; 2012 Mar; 113(3):977-84. PubMed ID: 22034092
[TBL] [Abstract][Full Text] [Related]
39. Matriptase-2, a membrane-bound mosaic serine proteinase predominantly expressed in human liver and showing degrading activity against extracellular matrix proteins.
Velasco G; Cal S; Quesada V; Sánchez LM; López-Otín C
J Biol Chem; 2002 Oct; 277(40):37637-46. PubMed ID: 12149247
[TBL] [Abstract][Full Text] [Related]
40. Expression of mRNA for four subtypes of the proteinase-activated receptor in rat dorsal root ganglia.
Zhu WJ; Yamanaka H; Obata K; Dai Y; Kobayashi K; Kozai T; Tokunaga A; Noguchi K
Brain Res; 2005 Apr; 1041(2):205-11. PubMed ID: 15829229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
